摘要
目的探讨波立维联合拜阿司匹林治疗不稳定型心绞痛(UPA)的疗效和安全性。方法将UPA患者随机分为治疗组75例和对照组73例,治疗组用波立维75mg,1日1次,共7天,拜阿司匹林100mg,1日1次,共7天;对照组用安慰剂,1日1次,连续7天,拜阿司匹林100mg,1日1次,共7天。结果治疗组总有效率为94.7%,对照组为79.4%,两组疗效差异有显著性(P〈0.05)。结论治疗组较对照组起效快,作用强,效果好,安全性高。
Objective To investigate the efficacy and safety of using Clopidogrel combined with aspirin in treatment for unstable angina pectoris (UAP). Methods The UAP patients were randomly divided into two groups: the treatment group ( n = 75 ) and the control group ( n = 73). The patients in the treatment group took 75 mg Clopidogrel and 100 nag aspirin once a day for a week. The patients in the control group took Placebot once a day for a week.Results Curative effects of the treatment group was obviously better than that of the control group with the cure rate 94.7% vs 79,4%, which was really statistically meaningful (P〈 0.05). Conclusion The treatment in the first group has a quicker, stronger and better effect and is reliably safe.
出处
《国际医药卫生导报》
2012年第8期1145-1146,共2页
International Medicine and Health Guidance News
关键词
波立维联合拜阿司匹林
不稳定型心绞痛
疗效
Clopidogrel combined with Aspirin
unstable angina pectoris (UAP)
Curative effect